LN-514334
Pazopanib Related Compound 2 , 0.95 , 1226500-02-2
Update time: 2023-04-23
PRODUCT Properties
| Boiling point: | 844.7±75.0 °C(Predicted) |
| Density | 1.45±0.1 g/cm3(Predicted) |
| pka | 2.60±0.30(Predicted) |
Description and Uses
This compound is an impurity of Pazopanib (P210925). Pazopanib is an oral angiogenesis inhibitor targeting VEGFR and PDGFR.
